University Cancer Centers universitycancercentres
A Review of Breast Cancer Survivorship Issues from Survivors’ Perspectives Sureeporn Chumdaeng
How Naturists Can Fight Breast Cancer advertising
early detection Badrya Said
what do omani women know about breast cancer Badrya Said
NCCN BC OC Risk Assessment masoumeh.asgari
APFCB_News123 monika
APFCB News 2017 issue 1 monika
APFCB News 2017 Issue 1 2 monika
APFCB News 2017 final 3 monika
Platinum and ruthenium complexes : therapeutic potential in breast cancer Wiruanglong Punyain
WOMEN%27S+FRONTLINE+MAGAZINE+ISSUE+February+2017 womensfrontline
Newsletter October 2016 - Primary School Al Saad Indian School, Al Ain
Jahari's F.L.Y. & FiT Magazine 'October 2016".pdf Jahari
Hertz Newsletter 2015 Tracyleesullivan
Trivia on Breast Cancer dkbagchi
Trivia on Breast Cancer dkbagchi
Leukemoid reaction as a “prognostic marker” in breast cancer and review of literature iaim.editor
![Background:
Cyclin D1, a key regulator of G1 to S phase progression of the cell cycle, is strongly established as an oncogene with an important pathogenetic role in many human tumors; therefore any genetic variations that disturb the normal function of this gene product is ultimately a target for association with cancer risk and survival. Cyclin D1 silent mutation (G870A) in the splicing region of exon-4 enhances alternative splicing, resulting two CCND1 mRNA transcripts variant [a] and [b], in which transcript b has a longer half-life. It has been deduced that G870A polymorphism of the CCND1 gene may play a role in tumorigenesis. The aim of our study was to investigate the influence of CCND1 genotypes on the genetic susceptibility to breast cancer in Egyptian population.](https://online.pubhtml5.com/wwnf/ippy/files/shot.jpg)
Cyclin D1 gene polymorphism in Egyptian breast cancer women researchinbiology